9pe with an .85 eps seems like a good value to me
the only arguement that could be made for the bear case is if LF gets crushed by competition in the tablet war. keep in mind they have 60 to 70 other products but clearly this is their bread and butter. to this date I have seem no evidence whatsoever of LF even remotely taking any kind of hit by competition. if anything they seem to be doing better than ever. only reason to me that makes any sense of this stock tanking from 12's in sept and mid 9's recently to 7 besides fiscal cliff is people selling for tax reasons. lets face it LF was 2.58 for the low about 14 months ago so there's lots who had a double, triple and quadruple on their hands now going into next year where the tax rate could go from 15 to 20, 25 or 30 percent. that would come out to 10's of thousands or even hundreds of thousands in taxes for large shareholders. other than that for now fundamentals seem strong to me.
I have seen so many bounces here only to see new lows get put in. I am tempted to go back in like at 7 and sell at 10 if thats even possible. I watched it go from 60's to 70's, 50's to 60's, 30's to 40's, then a big move from like 27 to 42, then one from 9's to maybe 14's and back to 10's now. I think years ago MCP had problems due to prices of rare earths being so low. This is why estimates have come down from like 15eps to 7eps and now maybe 1eps by end of next year. I know tons of competition along with to much coming on line from everyone hurting all the rare earth businesses. Not sure if I should mess with this stock again? Would be really stupid to lose even more money. Just wish like I said could buy at 7 and sell at 10 or buy at 9 to 10 and sell at 14 - 15 area. Thats all.
PT's by snalysts when I was holding were in the 90 to 125 range. Hard to believe now. What a pump and dump scam by insiders who sold tons in the 50's area. Shorts did warn me all along I just didn't listen. So sorry I didn't cause it's me who is hurt in the end.
Lost $60,000 here painfully. Had I held to the 10's I would have lost almost everything. I was in and out selling at 62 then rebuying at 58 then selling at 52 then rebuying at 46 the finally selling at 37. Painful -extremely painful. MCP to earn maybe 40 to 50 cents this year and maybe 90 something cents for 2013 a share. Buying at 9 or 10 probably not to bad now but I wouldn't be shocked to see it fall to the 5 to 7 area as someone posted here. Only thing "RARE" these days for me at least is money in my account.
Been in this 19 to 25 trading zone which feels like forever. I did well with CIE early this year. I got lucky buying in at 22 and then within a week later in shot to 36.50 for me. I sold at 34.50 that day when the stock was up 53%. Then I rebought it at 31.50 thinking 40 - 42 would come. It hit I think 33's or 34's again but then had a secondary at 28. Stock tanked to 28's then eventually down to 19. Then as said here been holding firm in the low 20's pretty well. My guess is since it's fully funded thru 2013 is it will hold well in the 19 - 22 area unless a big market selloff comes then maybe explode to 30's again if there's another big successful oil finding. Most targets are in the 36 to 42 range. I won big here then lost alittle rebuying at 31.50 and selling at 29 on my second go around. I am really tempted to get back in and either hold for a huge surge or maybe dump it if I bought at 21 - 22 and it hit only 25ish from there. Besides the sideways pattern do you see it going back to it's 52 week high ever again or even the low 40's on a big find?
Leap Frog Brushes Off Competition Worries and 4 Stock Analyses to Eye
By Deann Marin | More Articles
September 28, 2012
Scripps Networks Interactive, Inc. (NYSE:SNI): Needham raised their price target for Scripps Networks Interactive, Inc. to reflect their fiscal year 2013 earnings estimate of $3.77 and keeps a Buy rating on the stock.
Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ): After meeting with Jazz Pharmaceuticals, Inc.’s management, Oppenheimer believes that investors are drawing “inappropriate parallels” between Jazz’s Xyrem and Questcor’s (NASDAQ:QCOR) Acthar drug. The firm thinks that concerns over Xyrem pricing are unwarranted and they maintain a $66 target and Outperform rating on Jazz.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now
Research In Motion Limited (NASDAQ:RIMM): Even after Research in Motion Limited reported better than expected results, Oppenheimer continues to anticipate that the company’s business will deteriorate over time. The firm maintains a Perform rating on their shares.
Pier 1 Imports Inc. (NYSE:PIR): After meeting with Pier 1′s Chief Financial Officer, Oppenheimer believes that the company is executing their three year strategic plan very well. The firm thinks the company’s online sales effort is encouraging and it maintains an Outperform rating on the stock.
LeapFrog Enterprises Inc. (NYSE:LF): BMO Capital believes that LeapFrog Enterprises Inc.’s stock has been pressured recently by fears of emerging competition in the children’s tablet space, but the firm thinks that the competition isn’t new and is targeting older children. LeapFrog’s LeapPad 2 seems to be selling very well. The firm maintains a $15 target and Outperform rating.
Not looking good for BKS. Was on deaths door until the Microsoft deal but I don't think it's out of the woods yet. Maybe too little to late for BKS at this point.
I think so because Westport is in far better shape now then it was earlier this year. $48 doesn't seem that far away to me given all the wonderful news lately.
This stock will NEVER see 45 a share and I'm being to wonder if it will ever see 35 a share again? Been extremely disappointing stock to own even though I still feel it's undervalued when compared to alot of stocks out there but it sure doesn't trade as if it is.
I have 300,000 in tax losses here. Had my account go from 420,000 to 120,000 ridding this from 92 to 26 a share years ago. I ruined my life over this stock. I take full blame but painfully bought into Jim Cramers stock of the year for 2007. Said it was going to 240 after the Euronext deal, Wow what a call as it tanked to 14. What a disaster of a stock but what a fool I was, hell fool I am.
Their Super Bull case would see a target of $68.
Those two estimates are based upon a full NAV of $76.
Does this mean Morgan Stanley thinks 68 - 76 per share is possible based on full exploration results?
The newbies set up buying at year end and lows of 2012 will make out very nicely here. Molycorp has the funding and their production will still produce a nice EPS over the next few years.